글로벌 심폐 운동 테스트 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

심폐 운동 테스트 시장 분석

심폐 운동 검사 시장은 신체 활동 중 심장 및 폐 기능을 평가하는 데 필수적인 도구로 성장하고 있으며, 호흡기 및 심혈관 건강에 대한 통찰력을 제공합니다. 심폐 운동 검사는 병원, 진단 센터 및 전문 병원에서 호흡곤란, 피로, 운동 불내증과 같은 증상이 있는 환자를 평가하여 심부전, 만성 폐쇄성 폐질환 (COPD), 폐 고혈압과 같은 상태를 진단하는 데 널리 사용됩니다. 이 분야의 최근 개발은 정확성과 사용자 친화성을 개선하기 위해 고급 센서와 데이터 분석을 통합하는 데 중점을 두고 있으며, 운동 중 환자를 보다 정확하게 모니터링할 수 있습니다. 디지털 건강 기술과 웨어러블 기기 도 심폐 운동 검사 분야에 진출하여 검사를 보다 쉽게 ​​이용할 수 있게 하고 재택 모니터링에 대한 유용성을 확대하고 있습니다. 이러한 시스템에 대한 수요는 심혈관 및 호흡기 질환의 유병률 증가와 예방 건강 관리에 대한 인식 증가로 인해 촉진되어 향후 몇 년 동안 시장이 지속적인 성장과 기술 발전을 이룰 수 있는 위치에 있습니다.

심폐 운동 테스트 시장 규모

글로벌 심폐 운동 테스트 시장 규모는 2023년에 36억 7천만 달러로 평가되었으며, 2031년까지 50억 6천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 4.10%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

심폐 운동 테스트 시장 동향

“ 웨어러블 디바이스 및 원격 모니터링 솔루션”

심폐 운동 검사 시장은 의료 서비스 제공자가 스트레스 상황에서 심장과 폐 기능을 평가하고 귀중한 진단 통찰력을 제공하기 위해 이 기술을 점점 더 많이 사용함에 따라 빠르게 진화하고 있습니다. 이 시장의 혁신은 인공 지능 (AI)과 고급 데이터 분석을 통합하여 정확하고 실시간 분석을 허용함으로써 검사 정확도와 효율성을 향상시키는 데 중점을 두고 있습니다. 주목할 만한 추세는 웨어러블 기기와 원격 모니터링 솔루션의 증가로, 심폐 검사를 지속적으로 또는 집에서 사용하기에 더 쉽게 만들며 특히 만성 질환 관리에 유익합니다. 이 기술 변화는 예방 건강 관리와 개인화된 의학에 대한 증가하는 수요와 일치합니다. 이러한 혁신이 계속됨에 따라 심폐 운동 검사는 심혈관 및 호흡기 질환의 조기 발견 및 관리에 중요한 역할을 할 것으로 예상됩니다.

보고 범위 및 심폐 운동 테스트 시장 세분화         

심폐 운동 테스트 시장 정의

Cardiopulmonary exercise testing is a non-invasive diagnostic procedure that assesses how well the heart, lungs, and muscles work together during physical activity. By monitoring parameters such as oxygen uptake, carbon dioxide production, and heart rate, this test provides comprehensive information about a patient’s cardiovascular and respiratory health. It helps identify the cause of symptoms such as shortness of breath and fatigue, evaluate fitness levels, and diagnose conditions such as heart failure, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. This method is especially valuable in assessing exercise tolerance, guiding treatment plans, and monitoring the effectiveness of interventions.

Cardiopulmonary Exercise Testing Market Dynamics

Drivers

• Rising Prevalence of Heart Failure

The rising incidence of heart and lung conditions, including heart failure, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension, is significantly increasing the demand for diagnostic tools that can provide thorough evaluations of cardiopulmonary health. As these conditions become more prevalent, there is a growing need for precise diagnostic methods that help clinicians assess how effectively the heart and lungs function together, especially under physical stress. Cardiopulmonary exercise testing meets this need by offering valuable insights into a patient’s cardiovascular and respiratory systems, helping to detect abnormalities early and guide personalized treatment. This increasing prevalence of cardiopulmonary disorders thus serves as a critical market driver, supporting the expanded use of these advanced diagnostic tools.

•  Rising Demand for Personalized Medicine

Cardiopulmonary exercise testing plays a key role in supporting personalized treatment plans by offering comprehensive insights into a patient’s unique fitness level and health status. This detailed information allows healthcare providers to develop customized interventions that address each patient's specific cardiopulmonary needs, improving the effectiveness of treatments and enhancing patient outcomes. The growing emphasis on personalized healthcare solutions has increased the demand for diagnostic tools that offer such individualized data. By aligning with this trend, cardiopulmonary exercise testing enables a more targeted approach to care, making it a powerful driver in the market as providers and patients prioritize tailored, patient-centric healthcare strategies.

Opportunities

• Rise of Telemedicine

The rise of telemedicine presents a valuable opportunity to integrate cardiopulmonary exercise testing into remote patient monitoring systems. This integration allows healthcare providers to conduct tests and evaluate patient health virtually, making diagnostic services more accessible to individuals, particularly those living in rural or underserved areas where access to specialized care may be limited. By facilitating remote assessments, telemedicine can significantly reduce the barriers to healthcare, enabling timely interventions and continuous monitoring of patients with chronic conditions. This shift enhances the convenience for patients and expands the market for cardiopulmonary exercise testing, aligning with the increasing demand for innovative healthcare solutions that prioritize accessibility and patient-centered care.

• Growing Emphasis on Preventive Healthcare

As healthcare systems place a greater emphasis on preventive measures and early detection of diseases, the demand for cardiopulmonary exercise testing as a routine assessment tool is expected to increase significantly. This proactive approach to health management enables healthcare providers to identify potential cardiovascular and respiratory issues before they escalate into more serious conditions. By incorporating cardiopulmonary exercise testing into standard practice, clinicians can monitor patient health more effectively, tailor treatment plans, and enhance overall outcomes. This growing focus on prevention and early intervention presents a substantial market opportunity, encouraging the widespread adoption of cardiopulmonary exercise testing services across various healthcare settings.

Restraints/Challenges

• Competition from Alternative Testing Methods

Cardiopulmonary exercise testing faces significant competition from other diagnostic modalities, such as echocardiography and various imaging techniques, which are often more familiar to healthcare providers and may offer more cost-effective solutions. These alternatives can be preferred by clinicians who are accustomed to their use or those seeking quicker diagnostic methods without the need for patient exertion. This competitive landscape can restrict the market share of cardiopulmonary exercise testing, making it more challenging for these advanced diagnostic tools to gain widespread adoption. As a result, healthcare providers may opt for established modalities, hindering the growth potential of cardiopulmonary exercise testing in clinical settings.

• High Implementation Costs

The initial investment required for cardiopulmonary exercise testing equipment and technology can be significant, creating a substantial barrier for smaller healthcare facilities and clinics that operate with limited budgets. This high upfront cost encompasses not only the purchase of specialized testing equipment but also the necessary software, maintenance, and training for staff. As a result, some institutions may hesitate to invest in these advanced diagnostic tools, opting instead for less expensive alternatives that do not require such a financial commitment. This restraint can impede the broader adoption of cardiopulmonary exercise testing, limiting access to this critical diagnostic service for patients.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Cardiopulmonary Exercise Testing Market Scope

The market is segmented on the basis of product, application, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Single-Photon Emission Computed Tomography (SPECT)
• Cardiopulmonary Exercise Testing (CPET) Systems
• Echocardiogram
• Pulse Oximeters
• Stress Blood Pressure Monitors
• Others

Application

• Oxygen Uptake
• Carbon Dioxide
• Minute Ventilation
• Anaerobic Threshold

End-User

• Diagnostic Centers
• Ambulatory Centers
• Clinics and Hospitals
• Others

Cardiopulmonary Exercise Testing Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product, application, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is set to lead the cardiopulmonary exercise testing market from 2024 to 2031, driven by the increasing prevalence of cardiovascular and pulmonary disorders, including arrhythmia, heart failure, ischemic heart disease, dyspnea, and heart valve issues. The growing awareness among healthcare professionals regarding the benefits of cardiopulmonary exercise testing, coupled with the rising incidence of lifestyle-related diseases, further supports this trend. Additionally, the region's advanced healthcare infrastructure provides a strong foundation for the widespread adoption of these diagnostic tools.

Asia-Pacific region is experiencing significant growth in the cardiopulmonary exercise testing market, driven by the rising prevalence of cardiovascular and respiratory diseases. Factors such as urbanization, an aging population, and changing lifestyles contribute to the increased incidence of these health conditions. Additionally, healthcare investments and improvements in medical infrastructure are enhancing the accessibility and quality of diagnostic services throughout the region. Growing awareness among healthcare professionals and patients about the importance of early diagnosis and preventive care is further fueling demand for cardiopulmonary exercise testing. As these trends continue, the Asia-Pacific market presents numerous opportunities for expansion in this vital healthcare sector.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Cardiopulmonary Exercise Testing Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Cardiopulmonary Exercise Testing Market Leaders Operating in the Market Are:

• Thermo Fisher Scientific Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Care Quality Commission (U.K.)
• COSMED srl (Italy)
• GENERAL ELECTRIC COMPANY (U.S.)
• Cardinal Health (U.S.)
• Masimo (U.S.)
• Halma plc (U.K.)
• Hill-Rom Services, Inc. (U.S.)
• SCHILLER AG (Switzerland)
• VYAIRE (U.S.)
• MGC DIAGNOSTICS CORPORATION (미국)
• NIHON KOHDEN CORPORATION (일본)

심폐 운동 테스트 시장의 최신 동향

• 2022년 2월, InBody는 개인이 집에서 편안하게 필수 건강 지표를 스스로 기록하고 모니터링할 수 있는 자동 혈압 모니터인 BP 170을 공개했습니다. 이 혁신적인 기기는 사용자가 혈압 수치를 추적하고 심혈관 건강을 보다 효과적으로 관리할 수 있는 편리한 솔루션을 제공합니다. 사용자 친화적인 디자인의 BP 170은 중요한 모니터링을 접근 가능하고 간단하게 만들어 개인 건강 관리를 향상시킵니다.
• 2022년 1월, Aktiia는 환자와 의료 전문가 모두를 위해 맞춤화된 차세대 임상용 웨어러블을 대표하는 24/7 혈압 모니터를 미국에서 출시한다고 발표했습니다. 소비자용 웨어러블은 의료 커뮤니티에서 수용과 신뢰를 얻는 데 어려움을 겪었지만(의사의 81%가 소비자용 웨어러블 데이터에 따라 치료 결정을 내리지 않을 것이라는 사실에서 입증됨) 유럽 전역의 의사는 이미 Aktiia의 기술을 활용하여 환자 치료를 개인화하고 있습니다. 이 혁신적인 장치는 소비자 건강 추적과 임상적 신뢰성 간의 격차를 메우고 지속적인 모니터링을 통해 환자 결과를 개선하는 것을 목표로 합니다.
• 2020년 6월, 미국에 본사를 둔 MGC Diagnostics는 역시 미국에 위치한 Monitored Therapeutics, Inc.(MTI)와 유통 계약을 체결했습니다. 이 파트너십에 따라 MGC Diagnostics는 진단 장비 및 심폐 제품 분야의 전문성을 활용하여 환자에게 가정용 솔루션을 제공합니다. 이 협업은 가정 간병 환경에서 고급 진단 도구에 대한 접근성을 높여 의료 전문가를 지원하는 것을 목표로 합니다.
• 2020년 Cortex는 세계에서 가장 스마트한 실내 자전거로 알려진 Wattbike AtomX를 출시했습니다. 이 혁신적인 제품은 포괄적인 분석을 위해 설계되어 사용자가 심박수를 모니터링하고, 폐 기능을 평가하고, 혈관 및 대사 시스템을 검사할 수 있습니다. Wattbike AtomX는 피트니스 기술의 상당한 발전을 나타내며, 건강 및 성과 평가에 대한 귀중한 통찰력을 제공합니다.

SKU-34013